AT&T's Pain, Verizon's Q3 Test
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
VZ enters its Q3 report on Monday with the clearest pressure in the peer group not on Verizon itself, but on the stock it is most closely correlated with.
T dropped 8% on Friday alone and is down 10.7% on the week, a brutal move that reset expectations across the entire sector. Against that backdrop, Verizon's 0.3% weekly decline to $44.66 looks like resilience, though the stock has shed nearly 4% over the past month. Short interest on VZ is a modest 2.1% of free float, little changed on the week after edging down 2.8% over the past five sessions. That level is too low to be a structural story. The more interesting data this week sits in how positions shifted as AT&T's results landed.
The borrow market remains completely unthreatening. Availability is vast: roughly 63 shares are available to lend for every one currently borrowed, which is actually up from last week's 57-to-1 ratio cited in the prior note. Borrowing costs ticked up slightly to 0.41% but remain near their lowest levels of the past month. There is nothing in the lending market that points to short sellers building a case. The ORTEX short score of 33.97 is consistent with that: it has been drifting gently lower over the past two weeks, from 35.4 on October 12 to under 34 now.
Options traders have become a fraction more cautious this week, though not dramatically so. The put/call ratio edged back to 0.79 after touching 0.83 mid-week, sitting about 1.3 standard deviations above its 20-day average. That is a mild uptick in hedging demand, not a panic signal, and the ratio remains well short of its 52-week high of 0.95. Retail attention is running high: Wikipedia page views for Verizon carry a z-score of 2.2 against its own trailing 90 days, the most elevated reading among the company's tracked datasets, which likely reflects earnings anticipation rather than any fundamental shift.
The Street's positioning is broadly constructive but not aggressively so. The consensus mean price target of $51.24 implies about 15% above the current price, though the most recent analyst moves have been trims rather than lifts. Scotiabank cut its target twice in October, from $52.50 to $50, while maintaining its Sector Outperform rating. Those reductions came after Morgan Stanley, TD Cowen and others all raised targets following the Q2 print in late July. The EV/EBITDA multiple of 6.5 and a PE of 8.7 keep VZ in cheap-telecom territory. The dividend score ranks in the 84th percentile of the universe, and the earnings yield factor ranks 79th, reflecting the income case that drives much of the institutional base. BlackRock holds 9.6% and added 30 million shares in the most recent reported quarter, a meaningful add for the largest holder.
The insider picture adds little signal this week. Kyle Malady, EVP and Group CEO of Verizon Business, has sold 1,100 shares every Monday under a pre-arranged 10b5-1 plan, a mechanical schedule that has been running since at least August. These are small, scheduled disposals, not discretionary selling, and carry no informational weight. Net insider value over 90 days is a negative $525,000, entirely attributable to Malady's programme.
The Q3 results on Monday will tell whether the subscriber growth strategy that prompted those target raises in July is holding. AT&T's sharp move this week has reset what the market may accept as a pass or fail.
Stocks in this article
See the live data behind this article on ORTEX.
Open VZ on ORTEX →How this article was generated
- Generated
- 24 Oct 2026, 20:07
- Data as of
- 24 Oct 2026, 20:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.